Stage IIIB Breast Cancer Recruiting Phase 3 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs